中文别名：
化合物 T13386;4-(2-(二氟甲基)-1H-苯并[D]咪唑-1-基)-N-(2-甲基-1-(2-(1-甲基哌啶-4-基)苯基)丙-2-基)-6-吗啉基-1,3,5-三嗪-2-胺;化合物ZANDELISIB;4-[2-(二氟甲基)-1H-苯并咪唑-1-基]-N-[1,1-二甲基-2-[2-(1-甲基-4-哌啶基)苯基]乙基]-6-(4-吗啉基)-1,3,5-三嗪-2-胺
英文别名：
4-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-N-(2-methyl-1-(2-(1-methylpiperidin-4-yl)phenyl)propan-2-yl)-6-morpholino-1,3,5-triazin-2-amine;EOS-60789;PWT-143;Zandelisib;1,3,5-Triazin-2-amine, 4-[2-(difluoromethyl)-1H-benzimidazol-1-yl]-N-[1,1-dimethyl-2-[2-(1-methyl-4-piperidinyl)phenyl]ethyl]-6-(4-morpholinyl)-;4-[2-(difluoromethyl)-1H-1,3-benzodiazol-1-yl]-N-{2-methyl-1-[2-(1-methylpiperidin-4-yl)phenyl]propan-2-yl}-6-(morpholin-4-yl)-1,3,5-triazin-2-amine;4-[2-(difluoromethyl)benzimidazol-1-yl]-N-[2-methyl-1-[2-(1-methylpiperidin-4-yl)phenyl]propan-2-yl]-6-morpholin-4-yl-1,3,5-triazin-2-amine;PWT143,3-kinase,Phosphatidylinositol,Zandelisib,inhibit,ME401,Phosphoinositide 3-kinase,PWT-143,PWT 143,antineoplastic,PI3K,ME-401,ME 401,Inhibitor,p110δ
